Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
32.81
-1.38 (-4.04%)
Jun 2, 2026, 3:00 PM CST
SHA:603590 Market Cap
SHA:603590 has a market cap or net worth of 5.17 billion as of June 2, 2026. Its market cap has increased by 5.85% in one year.
Market Cap
5.17B
Enterprise Value
5.00B
Revenue
917.99M
Ranking
n/a
PE Ratio
30.97
Stock Price
32.81
Market Cap Chart
Since August 27, 2018, SHA:603590's market cap has decreased from 5.61B to 5.17B, a decrease of -7.83%. That is a compound annual growth rate of -1.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 5.39B | -14.79% |
| Dec 31, 2025 | 6.32B | 69.72% |
| Dec 31, 2024 | 3.72B | -37.51% |
| Dec 29, 2023 | 5.96B | 52.69% |
| Dec 30, 2022 | 3.90B | -23.24% |
| Dec 31, 2021 | 5.08B | -12.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suzhou Fengbei Biotech Stock | 6.32B |
| Chengdu Kanghua Biological Products | 6.20B |
| Wuhan Keqian Biology Co.,Ltd | 6.10B |
| Shanghai OPM Biosciences | 6.07B |
| Anhui Huaheng Biotechnology | 5.85B |
| Novogene | 5.73B |
| Shenzhen Weiguang Biological Products | 5.72B |
| Hangzhou Biotest Biotech | 5.58B |